Therefore, for long-term follow-up of SSc patients, detecting S100A8 and CXCL4 levels in plasmacytoid dendritic cell supernatant may be an efficient and convenient way to assess the risk of ILD. This evidence concerns the gene S100A8 and interstitial lung disease.